Infant Formula Supplemental Appropriations Act, 2022
This bill provides $28 million in emergency supplemental appropriations to address the shortage of infant formula in the United States.
Specifically, the bill provides appropriations for the Food and Drug Administration (FDA) to (1) address the current shortage of FDA-regulated infant formula and certain medical foods in the United States; and (2) prevent future shortages, including by taking the steps that are necessary to prevent fraudulent products from entering the U.S. market.
Infant Formula Supplemental Appropriations Act, 2022
This bill provides $28 million in emergency supplemental appropriations to address the shortage of infant formula in the United States.
Specifically, the bill provides appropriations for the Food and Drug Administration (FDA) to (1) address the current shortage of FDA-regulated infant formula and certain medical foods in the United States; and (2) prevent future shortages, including by taking the steps that are necessary to prevent fraudulent products from entering the U.S. market.
Read the first time. Placed on Senate Legislative Calendar under Read the First Time. (Legislative Day 5/17/2022).
Placed on Senate Legislative Calendar under General Orders. Calendar No. 374.
Res. 1124 passed House.
Res. 1124. (consideration: CR H5158-5163)
350, H.R. 7688 and H.R. 7790. Provides for one of hour of general debate and one motion to recommit for each bill. Resolution also provides for en bloc suspension authority.
Hinson moved to recommit to the Committee on Appropriations. (text: CR H5163)
(consideration: CR H5165-5166)
202 - 218 (Roll no. 219).
On passage Passed by the Yeas and Nays: 231 - 192 (Roll no. 220).
231 - 192 (Roll no. 220). (text: CR H5158)
Res. 1124 Reported to House. Rule provides for consideration of H.R. 350, H.R. 7688 and H.R. 7790. Provides for one of hour of general debate and one motion to recommit for each bill. Resolution also provides for en bloc suspension authority.